Freda Lewis-Hall - 05 Aug 2025 Form 4 Insider Report for CDT Equity Inc. (CDT)

Reporting relationship: Director
Issuer ticker: CDT
Reported as of: 05 Aug 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Aug 2025, 16:30:28 UTC
Prior SEC filing: 02 Jul 2025
Next SEC filing: 25 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Freda Lewis-Hall

Key filing fact

Freda Lewis-Hall filed Form 4 for CDT Equity Inc. (CDT) on 26 Aug 2025.

Key facts

This page summarizes Freda Lewis-Hall's Form 4 filing for CDT Equity Inc. (CDT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 26 Aug 2025, 16:30.

Change

Previous filing in this sequence was filed on 02 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001437909 Primary reporting owner

Lewis-Hall Freda C

Relationship: Director
Address: 4581 TAMIAMI TRAIL NORTH,, SUITE 200, NAPLES
Signature: /s/ Freda Lewis-Hall
Signature date: 26 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDT transaction

Common Stock

Award

Transaction value: $0
Shares: +35,000
Change %: +1010%
Price: $0.000000
Shares after: 38,466
Date: 12 Aug 2025
Ownership: Direct
Footnotes: F1

CDT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,335
Date: 05 Aug 2025
Ownership: See Footnote
Footnotes: F2

CDT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 344
Date: 05 Aug 2025
Ownership: See Footnote
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +15,000
Change %
Price: $0.000000
Shares after: 15,000
Date: 05 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,000
Exercise price: $1.89
Footnotes: F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents restricted stock units ("RSUs") received on August 12, 2025, in exchange for past services, having a value equal to approximately $60,900 based on the closing price per share of the Issuer's common stock on August 12, 2025. The RSUs vest immediately upon grant.

Footnote F2

The shares are held of record by Intelmed LLC ("Intelmed"). Ms. Lewis-Hall is the Managing Director of Intelmed and in such capacity has voting and investment discretion with respect to the shares held of record by Intelmed. By virtue of this relationship, Ms. Lewis-Hall may be deemed to share beneficial ownership of the shares held of record by Intelmed. Ms. Lewis-Hall disclaims any such beneficial ownership except to the extent of her pecuniary interest therein.

Footnote F3

The shares are held by Ms. Lewis-Hall's spouse, Mr. Emerson Hall, Jr. As Mr. Hall's spouse and by virtue of their relationship, Ms. Lewis-Hall may be deemed to share beneficial ownership of such shares held by record by Mr. Emerson Hall, Jr. Ms. Lewis-Hall disclaims any such beneficial ownership except to the extent of her pecuniary interest therein.

Footnote F4

Represents options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan, which were granted at the conclusion of the Issuer's 2025 annual meeting of stockholders.

Footnote F5

The options vest immediately upon grant.